As previously, KRAS-mutated LUAD tumors had a highly significant increase in both PDL1 TPS as well as CD274 mRNA expression, though this was not observed in squamous cell carcinoma presumably because of the relative lack of KRAS mutations (Fig. 2H and I). The gene discussed is KRAS; the disease is squamous cell carcinoma.